Neel Desai

Company: Biogen

Job title: Business Development & Licensing Professional

Seminars:

Investor Panel: Navigating Partnerships, & Investment Challenges in Psychosis Drug Development 3:00 pm

Explore the scientific, regulatory, and commercial uncertainties that make psychosis R&D a uniquely high-risk category, and how these risks shape both pharma and investor interest Discuss how innovative startups and emerging biotech companies can forge mutually beneficial relationships with pharma and venture investors What makes a small biotech compelling? Insights into what large pharma and…Read more

day: Day Two

Roundtable Discussion: Benchmarking Opportunities, Risks & Challenges of Studying & Therapeutically Targeting Psychotic Symptoms in Dementia, Bipolar, PTSD, Depression, Autism, ADHD & More 5:00 pm

Practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas: Dementia-Associated Psychosis Bipolar Augmentation Strategies Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open a wider audience debate. Read more

day: Day One